Hisamitsu Pharmaceutical Co Financial Overview
Hisamitsu Pharmaceutical Co's market cap is currently ¥308.63B. The company's EPS TTM is ¥62.31; its P/E ratio is 15.64; and it has a dividend yield of 2.48%. Hisamitsu Pharmaceutical Co is scheduled to report earnings on January 9, 2025, and the estimated EPS forecast is ¥137.10. See an overview of income statement, balance sheet, and cash flow financials.
